NICE backing for combi inhalers4th April 2008
New guidance from the National Institute for Health and Clinical Excellence (NICE) has approved combination inhalers for patients with chronic asthma.
It says that for adults and children over the age of 12, who require both an inhaled corticosteroid (ICS) and a long-acting beta-2 agonist (LABA), a combination device should be considered to deliver the drugs. The guidance recommends GPs choose between combination treatment and separate devices, depending on therapeutic need or how likely the patient is to adhere to the treatment.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.